16,207 Shares in Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Bought by Cerity Partners LLC

Cerity Partners LLC purchased a new stake in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 16,207 shares of the real estate investment trust’s stock, valued at approximately $232,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. CWM LLC increased its position in Sabra Health Care REIT by 363.5% during the third quarter. CWM LLC now owns 1,780 shares of the real estate investment trust’s stock worth $25,000 after acquiring an additional 1,396 shares during the period. Signaturefd LLC grew its position in Sabra Health Care REIT by 45.2% in the 3rd quarter. Signaturefd LLC now owns 2,610 shares of the real estate investment trust’s stock worth $36,000 after purchasing an additional 813 shares during the last quarter. Headlands Technologies LLC bought a new position in shares of Sabra Health Care REIT during the 3rd quarter worth about $48,000. International Assets Investment Management LLC increased its holdings in shares of Sabra Health Care REIT by 748.0% during the 4th quarter. International Assets Investment Management LLC now owns 4,681 shares of the real estate investment trust’s stock worth $67,000 after purchasing an additional 4,129 shares during the period. Finally, Annis Gardner Whiting Capital Advisors LLC acquired a new position in shares of Sabra Health Care REIT during the third quarter valued at about $98,000. 99.40% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on the company. Deutsche Bank Aktiengesellschaft began coverage on Sabra Health Care REIT in a research report on Tuesday, January 30th. They set a “buy” rating and a $21.00 target price on the stock. Wedbush restated an “outperform” rating and set a $17.00 price objective on shares of Sabra Health Care REIT in a research report on Thursday, February 29th. Finally, Mizuho raised their target price on Sabra Health Care REIT from $15.00 to $17.00 and gave the stock a “buy” rating in a research report on Wednesday, January 3rd. Five analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $15.77.

Sabra Health Care REIT Stock Up 1.6 %

SBRA opened at $14.17 on Tuesday. The firm has a market cap of $3.28 billion, a price-to-earnings ratio of 283.40, a PEG ratio of 5.01 and a beta of 1.16. The company has a debt-to-equity ratio of 0.86, a quick ratio of 3.41 and a current ratio of 3.41. The firm’s 50-day simple moving average is $14.07 and its 200-day simple moving average is $14.04. Sabra Health Care REIT, Inc. has a twelve month low of $10.30 and a twelve month high of $14.91.

Sabra Health Care REIT Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, February 29th. Shareholders of record on Tuesday, February 13th were paid a dividend of $0.30 per share. The ex-dividend date was Monday, February 12th. This represents a $1.20 annualized dividend and a yield of 8.47%. Sabra Health Care REIT’s dividend payout ratio is 2,400.00%.

About Sabra Health Care REIT

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.